New Research Reveals Surprising Benefits of GLP-1 Medications for Workplace Productivity A recent study based on Danish data has made a groundbreaking discovery about the impact of GLP-1 medications on employee absenteeism. The study found that individuals taking GLP-1s, a class of medications commonly used to treat type 2 diabetes, experienced significantly fewer long-term absences from work. Specifically, the research revealed that those on GLP-1s had 17% less long-term absences compared to their counterparts. This finding has significant implications for employers and policymakers seeking to improve workplace productivity and reduce the economic burden of absenteeism.
Based on Danish data, the study found those on GLP-1s had 17% less long-term absences.
